Seroprevalence measurements reveal a higher incidence of asymptomatic SARS-CoV-2 infections among residents of three federal German states SARSCoV2 COVID19 Germany Seroprevalence AsymptomaticCOVID
By Dr. Chinta SidharthanDec 20 2022Reviewed by Aimee Molineux In a recent study published in PLOS ONE, researchers measured the seroprevalence against severe acute respiratory syndrome coronavirus 2 in blood donors from the states of Hesse, Lower Saxony, and North Rhine-Westphalia in Germany to determine the incidence of undetected asymptomatic SARS-CoV-2 infections.
About the study In the present study, the researchers used the remaining plasma samples from regular blood donors for anti-SARS-CoV-2 IgG antibody screening. Enzyme-linked immunosorbent assay was used for the initial detection of the viral spike protein. The seropositive samples were then subjected to chemiluminescent microparticle immunoassay to detect anti-receptor binding domain IgG antibodies. Anti-nucleocapsid antibodies were measured using a fully automated serological ELISA.
All the 88 samples that were analyzed for neutralizing antibodies and antibody avidity revealed a rapid decay of neutralizing and binding IgG antibodies against SARS-CoV-2 and low avidity during the 181 days of follow-up. When the results were analyzed according to sex, the IgG antibodies against SARS-CoV-2 were seen to decline more rapidly in males than females. Furthermore, neutralizing antibody persistence and increased avidity were stronger in female donors than in males.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2 biorxivpreprint PittHealthSci antibody antibodies vaccine vaccination SARSCoV2 COVID19 covid coronavirus
Consulte Mais informação »
Milk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infectionMilk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infection medrxivpreprint UCSF SARSCoV2 COVID19 Booster Vaccine Vaccination
Consulte Mais informação »
What is the impact of cholesterol on SARS-CoV-2 Spike protein-mediated membrane fusion?Researchers assessed the impact of ceramide (CER) and cholesterol (CHOL) on membrane fusion mediated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Consulte Mais informação »
An assessment of T cell and antibody immunity against SARS-CoV-2 VOCs and the effect of booster shotsA new study in the journal Vaccines aimed to analyze the long-term kinetics of SARS-CoV-2 specific T cell and humoral responses following primary and booster vaccinations in previously infected individuals.
Consulte Mais informação »
Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker populationRise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population researchsquare USC UCIrvine antibody SARSCoV2 healthcare mRNA vaccine vaccination COVID19 coronavirus covid
Consulte Mais informação »
Researchers generate a remodeled live-attenuated measles vaccine capable of driving nAb responses against SARS-CoV-2 spike proteinResearchers generate a remodeled live-attenuated measles vaccine capable of driving nAb responses against SARS-CoV-2 spike protein biorxivpreprint IcahnMountSinai vaccine vaccination measles COVID19 covid
Consulte Mais informação »